127 related articles for article (PubMed ID: 12085446)
1. [Changes in the EEG rhythms in endogenous depressive disorders and the effect of pharmacotherapy].
Omel'chenko VP; Zaika VG
Fiziol Cheloveka; 2002; 28(3):30-6. PubMed ID: 12085446
[No Abstract] [Full Text] [Related]
2. [EEG factor analysis in the treatment with antidepressants].
Bochkarev VK; Paniushkina SV; Nazmutdinov IG; Nikiforov AI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(10):120-5. PubMed ID: 2618217
[TBL] [Abstract][Full Text] [Related]
3. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
Iakovlev VA
Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
[No Abstract] [Full Text] [Related]
4. [Identification of antidepressants based on the characteristics of EEG spatial organization].
Monakhov KK; Paniushkina SV; Bochkarev VK; Nazmutdinov IG
Farmakol Toksikol; 1987; 50(4):25-9. PubMed ID: 3666113
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of levoprotiline and amitriptyline in endogenous depressions.
Faltus F; Molcan J; Svestka J; Náhunek K; Mrna B; Zapletálek M; Krekule P; Janecková E; Koníková M; Pazdírek S
Act Nerv Super (Praha); 1989 Dec; 31(4):279-80. PubMed ID: 2638109
[No Abstract] [Full Text] [Related]
6. [Correlations between the EEG pattern of sleep and depressive syndrome in patients with bipolar affective disorders before and during treatment with amitriptyline].
Ekiert H; Gogol Z; Jernajczyk W
Psychiatr Pol; 1983; 17(4):287-93. PubMed ID: 6657811
[No Abstract] [Full Text] [Related]
7. [Various physiological parameters as predictive factors in the pharmacotherapy of endogenous depression].
Załuska M; Wójcik M; Slósarska M
Psychiatr Pol; 1988; 22(1):39-45. PubMed ID: 3043505
[No Abstract] [Full Text] [Related]
8. Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter.
Müller DJ; Schulze TG; Macciardi F; Ohlraun S; Gross MM; Scherk H; Neidt H; Syagailo YV; Grässle M; Nöthen MM; Maier W; Lesch KP; Rietschel M
Pharmacopsychiatry; 2002 Jul; 35(4):157-8. PubMed ID: 12163988
[No Abstract] [Full Text] [Related]
9. [Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy].
Kool S; Schoevers R; Duijsens IJ; Peen J; van Aalst G; de Jonghe F; Dekker J
Tijdschr Psychiatr; 2007; 49(6):361-72. PubMed ID: 17611937
[TBL] [Abstract][Full Text] [Related]
10. [EEG patterns in the states of wakefulness and sleep during treatment with tricyclic antidepressive agents (imipramine, amitriptyline)].
Ekiert H; Gogol Z
Psychiatr Pol; 1983; 17(1):57-64. PubMed ID: 6353458
[No Abstract] [Full Text] [Related]
11. Quantitative EEG and functional mapping in treatment of major depression.
Saito M; Ohashi Y; Nobuhara K; Isotani T; Yagyu T; Saito A; Okajima Y; Saito N; Fukushima M; Kugimuki T
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():421A-422A. PubMed ID: 1498899
[No Abstract] [Full Text] [Related]
12. [Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses].
Gaertner HJ; Giedke H; Breyer-Pfaff U
Nervenarzt; 1984 Mar; 55(3):133-6. PubMed ID: 6717696
[No Abstract] [Full Text] [Related]
13. Tryptophan and tyrosine availability: relation to clinical response to antidepressive pharmacotherapy.
Møller SE; Larsen OB
Adv Biochem Psychopharmacol; 1984; 39():319-26. PubMed ID: 6380228
[No Abstract] [Full Text] [Related]
14. Pseudohallucinations associated with moclobemide: a case report.
Degner D; Kropp S; Porzig J; Grohmann R; Rüther E
Pharmacopsychiatry; 2005 Jul; 38(4):179-81. PubMed ID: 16025422
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of pharmaco-EEG in depression treated with moclobemide].
Wiśniewski G; Jakitowicz J; Nowicki Z; Pankiewicz P
Psychiatr Pol; 2002; 36(6 Suppl):93-8. PubMed ID: 12647427
[TBL] [Abstract][Full Text] [Related]
16. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
Diaz A; Fouilloux C; Ortiz S
Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
[No Abstract] [Full Text] [Related]
17. [Biochemical presynaptic and receptor adaptations during long-term antidepressive treatment].
Vetulani J
Psychiatr Pol; 1987; 21(3):190-8. PubMed ID: 2892220
[No Abstract] [Full Text] [Related]
18. Effects of antidepressant drugs on electroencephalography alpha power: importance of study duration.
Wiśniewski GS; McAllister-Williams RH; Jakitowicz J; Nowicki Z; Majkowicz M; Trzebiatowska IA
Biol Psychiatry; 2008 Nov; 64(10):e5-6; author reply e7. PubMed ID: 18801473
[No Abstract] [Full Text] [Related]
19. [What is psychological placebo therapy?].
Lahti I
Duodecim; 1995; 111(22):2180-2. PubMed ID: 9841180
[No Abstract] [Full Text] [Related]
20. [Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Koval'chuk VV
Vopr Onkol; 2007; 53(6):704-10. PubMed ID: 18416142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
